Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Geneva-based firm Alix Capital launches the first investable 'UCITS Alternative Index'

Tuesday, November 30, 2010
Opalesque Industry Update - Palaedino Asset Management, advisor to the Axiom Fund, and Alix Capital, provider of the UCITS Alternative Index are proud to announce the launch of the first investable “UCITS Alternative Index®”. The Axiom UCITS Alternative Investable Index Fund (“the Axiom Fund”) is a UCITS III SICAV registered with the CSSF in Luxemburg offering weekly liquidity. The new Fund aims to replicate the UCITS Alternative Blue Chip Index (“the Blue Chip Index”).

The objective of this Index is to provide a fair, reliable and unbiased representation of the UCITS absolute return performance. The Index consists of a sample of the 50 top equally weighted UCITS hedge funds. Fund selection follows transparent, rule-based and replicable selection criteria and is overseen by an Index Committee. The Blue Chip Index is rebalanced quarterly. Although it is still reserved for institutional clients, the Axiom Fund will shortly be registered in a number of European countries, including Switzerland, which will enable it to be accessible to the general public.

Alessandro Mauceri, CEO of Palaedino Asset Management, says: ”I strongly believe that UCITS alternative funds are not hype but are here to stay - especially in the aftermath of the 2008 problems encountered by offshore hedge funds, such as gates, side pockets and suspension. When investing in hedge funds, investors now demand the same level of protection as that offered by onshore regulated funds. This product will provide broad exposure to the performance of alternative strategies available in the UCITS III universe within a well-diversified and liquid product.”

Louis Zanolin, CEO of Alix Capital, says: “We are delighted and enthusiastic about this positive evolution of the UCITS Alternative Index. Since the launch of the different benchmarks we have received a great deal of interest in tracker products from a variety of investors. The Axiom Fund is therefore a natural evolution for the UCITS hedge funds in general and the UCITS Alternative Index in particular.”

(press release)

About the UCITS Alternative Index
The UCITS Alternative Index series is the industry's leading benchmark for UCITS hedge funds. The series of indices tracks the performance of both global and strategy-specific UCITS hedge funds; the UCITS Alternative Index series is equally weighted. The inception of the UCITS Alternative Index Global occurred on 1 January 2006, with that of all other indices on 1 January 2008. Information on performance is accessible on the UCITS Alternative Index website www.ucits-alternative.com. The UCITS Alternative Index is a registered trademark and Alix Capital is the exclusive agent for the UCITS Alternative Index.

About Palaedino Asset Management
Palaedino Asset Management is an arm of the Palaedino Group. The Group was set up in 2006 by skilled professionals. Palaedino Asset Management is an independent company which manages assets for institutional clients and high net-worth families. The Company specializes in inventive strategies with a focus on capital preservation. www.palaedinoam.ch.

About Alix Capital
Alix Capital is a Geneva-based investment company specializing in alternative investments. Founded by a team of experienced alternative investment specialists and the Palaedino Group, a Swiss-based private wealth-management company, Alix Capital provides research and advisory services to the institutional investor community in the field of absolute return investing. The Company is responsible for the calculation, licensing, branding and marketing of the UCITS Alternative Indices. Alix Capital also publishes the UCITS Alternative Quarterly Industry Report, the leading industry report dedicated to the UCITS hedge fund industry. www.alixcapital.com.


bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for